Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs) | Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine)

The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth. However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market's growth.

Download FREE PDF of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=297417

Top Companies covered in this Report-
ENTEROME Bioscience (France), Seres Therapeutics. (US), 4D pharma (UK), Evelo Biosciences (US), OptiBiotix Health (UK), Synlogic (US), Second Genome (US), Vedanta Biosciences (US), Ferring Pharmaceuticals (Switzerland), ViThera Pharmaceuticals (US), BiomX (Israel), DuPont (US), Kaleido (US), YSOPIA Bioscience (France), FlightPath (US), Finch Therapeutics (US), Quantbiome (DBA Thyrve, Inc.) (US), Viome, Inc. (US), DayTwo (US), BIOHM (US), Atlas Biomed (UK), Bione (India), Luxia Scientific (France), Sun Genomics (US), and Metabiomics (US)

Based on product, the human microbiome market is segmented as follows:
Probiotics
Prebiotics
Diagnostic Tests
Drugs
Other Products

Based on disease, the human microbiome market is segmented as follows:
Infectious Diseases
Endocrine and Metabolic Disorders
Gastrointestinal Diseases
Cancer
Other Diseases (cardiovascular diseases, neurological disorders, dermatology diseases, immune-modulated disorders, and hematological disorders.

Based on application, the human microbiome market is segmented as follows:
Therapeutics
Diagnostics

Based on type, the human microbiome market is segmented as follows:
FMT
Peptide
Live Biotherapeutic Product
Others

Based on region, the human microbiome market is segmented as follows:
North America
US
Canada
Europe
Asia Pacific
Rest of the World (RoW)

Based on the technology, the human microbiome research spending market is segmented as follows:
Genomics
Sequencing
16s rRNA sequencing method
Whole-genome sequencing method
Other Sequencing methods (shotgun metagenomic sequencing, transcriptomics, and targeted sequencing.)
Other Genomic Technologies (Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH), and DNA Microarrays)
Proteomics
Metabolomics

Get Discount on Purchase this Report @ https://www.reportsnreports.com/purchase.aspx?name=297417

The report segments the human microbiome market based on region (Asia Pacific, Europe, North America, and RoW), product (prebiotics, probiotics, drugs, diagnostic tests, and other products), technology (Genomics, Proteomics, and Metabolomics), application (therapeutics and diagnostics), disease (hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies, and other end users). The report also provides a comprehensive review of market drivers, opportunities, restraints, and challenges in the human microbiome market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall human microbiome market and its sub segments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Markets Covered For Human Microbiome Research Spending Market
1.3.3 Years Covered For The Study (Human Microbiome Research Spending Market)
1.3.4 Years Covered For The Study (Human Microbiome Market)
1.4 Currency
1.5 Stakeholders
1.6 Summary Of Changes

2 Research Methodology
2.1.1 Secondary Data
2.1.2 Primary Sources
Figure 1 Breakdown Of Primaries: Human Microbiome Market
2.2 Market Data Estimation And Triangulation
Figure 2 Data Triangulation Methodology
2.2.1 Market Estimation Methodology
Figure 3 Market Size Estimation Approach: R&D Spending Analysis-Based Estimation (For Human Microbiome Research Spending Market)
Figure 4 Human Microbiome Research Spending Market Size (USD Million): Final Market Size
2.2.2 Growth Rate Assumptions/Growth Forecast
Figure 5 Final Cagr Projections (2023-2029)
2.2.3 Potential Market Size Calculation For Human Microbiome Market
Figure 6 Human Microbiome Market Size Based On Epidemiology Approach
2.3 Insights From Primaries
Figure 7 Market Validation From Primary Experts
2.4 Research Assumptions

3 Executive Summary
Figure 8 Human Microbiome Market, By Product, 2023 Vs. 2029 (USD Million)
Figure 9 Human Microbiome Market Share, By Application, 2029
Figure 10 Human Microbiome Market, By Disease, 2024 Vs. 2029 (USD Million)
Figure 11 Geographical Snapshot Of Human Microbiome Market

4 Premium Insights
4.1 Human Microbiome: Market Overview
Figure 12 Increasing Focus On Human Microbiome Therapeutics Development To Drive Market Growth
4.2 Human Microbiome Market, By Type (2023 Vs. 2029)
Figure 13 Fmt To Dominate Human Microbiome Market In 2023
4.3 North America: Human Microbiome Market, By Product & Application (2023)
4.4 Human Microbiome Research Spending Market, By Country (2023-2029)
Figure 14 China To Grow At The Highest Cagr During Forecast Period

5 Market Overview
and more..

+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.